The prognostic value of CEA, βHCG, AFP, CA125, CA19-9 and C-erb B-2, (βHCG immunohistochemistry in advanced colorectal cancer
暂无分享,去创建一个
[1] T R Fleming,et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. , 1993, JAMA.
[2] S. Shousha,et al. HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies. , 1992, Journal of Clinical Pathology.
[3] E. Campo,et al. Prognostic value of CA 19.9 levels in colorectal cancer. , 1992, Annals of surgery.
[4] S. Pyrhönen,et al. Elevated CA19‐9 as the most significant prognostic factor in advanced colorectal carcinoma , 1992, Journal of surgical oncology.
[5] T. Wobbes,et al. Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas. , 1992, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[6] H. Wieand,et al. A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer , 1990, Cancer.
[7] A. Ullrich,et al. Expression of the p185 encoded by her2 oncogene in normal and transformed human tissues , 1990, International journal of cancer.
[8] J. Jessup,et al. Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis. , 1990, Journal of the National Cancer Institute.
[9] W. Gullick,et al. c‐erbB‐2 oncoprotein expression in primary human tumors , 1990, Cancer.
[10] Y. Shiloh,et al. Amplification of c‐myc and c‐erbB‐2 proto‐oncogenes in human solid tumors: Frequency and clinical significance , 1989, International journal of cancer.
[11] T. Kosaka,et al. Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis. , 1989, British Journal of Cancer.
[12] S. Hirohashi,et al. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. , 1989, Cancer research.
[13] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[14] Abraham Fuks,et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule , 1989, Cell.
[15] B Angus,et al. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. , 1989, Cancer research.
[16] S. Steinberg,et al. Determinants of survival in patients with unresectable colorectal liver metastases , 1989, Journal of surgical oncology.
[17] N. Kemeny,et al. Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement , 1989, Cancer.
[18] H. Deguchi,et al. Carcinoembryonic antigen and carbohydrate antigen 19‐9 levels of peripheral and draining venous blood in colorectal cancer patients correlation with histopathologic and immunohistochemical variables , 1988, Cancer.
[19] Y. Shiloh,et al. Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. , 1988, Cancer research.
[20] I. Fidler,et al. Growth potential of human colorectal carcinomas in nude mice: association with the preoperative serum concentration of carcinoembryonic antigen in patients. , 1988, Cancer research.
[21] B. Groner,et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. , 1988, Cancer research.
[22] E. Campo,et al. Human chorionic gonadotropin in colorectal carcinoma an immunohistochemical study , 1987, Cancer.
[23] H. Egami,et al. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system. , 1987, Gut.
[24] H. Egami,et al. Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System , 1986, The American journal of the medical sciences.
[25] R. Tubbs,et al. Measurement of a monoclonal‐antibody‐defined antigen (CA 19‐9) in the sera of patients with malignant and nonmalignant diseases comparison with carcinoembryonic antigen , 1985, Cancer.
[26] P. Wilkinson,et al. Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker. , 1984, British Journal of Cancer.
[27] N. Wolmark,et al. The Prognostic Significance of Preoperative Carcinoembryonic Antigen Levels in Colorectal Cancer: Results from NSABP Clinical Trials , 1984 .
[28] O. Mäkelä,et al. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. , 1984, British Journal of Cancer.
[29] R. Bast,et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.
[30] M. O'brien,et al. Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. , 1981, The American journal of medicine.
[31] H. Fox,et al. An immunohistochemical study of the significance of HCG secretion by large bowel adenocarcinomata. , 1979, Journal of clinical pathology.
[32] M. O’connell,et al. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma. , 1978, Annals of internal medicine.
[33] Ding‐Shinn Chen,et al. Serum alphafetoprotein in hepatocellular carcinoma , 1977, Cancer.
[34] M. Ostrander,et al. Human chorionic gonadotrophins (hCG) in nontrophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms , 1976, Cancer.
[35] T. Waldmann,et al. α-Fetoprotein in Nonneoplastic Hepatic Disorders , 1975 .
[36] T. Waldmann,et al. Serum α-Fetoprotein in Patients with Neoplasms of the Gastrointestinal Tract , 1975 .
[37] T. Waldmann,et al. The use of a radioimmunoassay for alpha‐fetoprotein in the diagnosis of malignancy , 1974, Cancer.
[38] G. Braunstein,et al. Ectopic production of human chorionic gonadotrophin by neoplasms. , 1973, Annals of internal medicine.